PBMT using 630 + 660 nm wavelengths transcutaneously at 7 cm above chest area irradiating lungs and heart regions of patients with acute, infectious respiratory syndrome alleviated their respiratory symptoms, mitigated pulmonary inflammation and hypoxia. PBMT could prevent more severe respiratory distress requiring emergency care and reduce the strain on healthcare. This case report's clinical experience can be the basis of future research evaluating oxygen saturation levels pre- and post-PBMT.
Keywords: acute respiratory distress syndrome; coronavirus; dyspnoea; hypoxemia; oxygenation; photobiomodulation; red light; viral pandemic.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.